The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Prof. Bereket has graduated from Ankara University, Medical School in 1986. After finishing pediatric residency training in 1991, he completed his fellowship in Pediatric Endocrinology at State University of New York at Stony Brook, USA in 1991-1996. He was appointed as Assistant Professor at Hacettepe University of Ankara in 1997. In 1999, he founded Pediatric Endocrinology division at Marmara University of Istanbul and is currently chief of the division and subspecialty training program. He was granted full professorship in 2003. Dr Bereket authored more than 160 peer-reviewed articles in international journals. He was awarded as outstanding young scientist by Turkish Academy of Sciences in 2001. He is a member of European Society for Pediatric Endocrinology (ESPE) and served in board of ESPE Bone Club and ESPE Summer school steering commitee in 2011-2015. He has served as, treasurer, vice president and President of Turkish Pediatric Endocrin Society between 2001-2007. He is associate editor of Journal of Clinical Research in Pediatric Endocrinology, Journal of Pediatric Endocrinology and Metabolism and in the editorial board of Hormone Research in Pediatrics. His main research interests are insulin-like growth factors, obesity, precocious puberty, and rickets.